Lung Function and Asthma Clinical Control in N-ERD Patients, Three-Year Follow-Up in the Context of Real-World Evidence.
Gandhi Fernando Pavón-RomeroRamcés Falfan-ValenciaKatia Vanessa Gutiérrez-QuirozEstivaliz Arizel De La O-EspinozaNancy Haydée Serrano-PérezFernando Ramírez-JiménezLuis M TeranPublished in: Journal of asthma and allergy (2023)
According to GINA guidelines, only one-third of patients with N-ERD can gradually achieve adequate lung function and good asthma control with a high ICS dosage. Only a very small portion of patients will require the continued use of a second medication as an LTRA to keep their asthma under control.